
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.


Investor Presentation
Q2 FY26
Investor Presentation
Q1 FY26
Investor Presentation
Q4 FY25
Investor Presentation
Q3 FY25
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Investor Presentation
Q2 FY25
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Investor Presentation
Q1 FY25
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Investor Presentation
Q4 FY24
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Investor Presentation
Q3 FY24
Healthcare
Hospitals / Medical Services
23,956 Cr
Moderate Risk
72.9
57.8
2.1
10.6
798.00
474.55
Sales CAGR
1Y
21.49%
3Y
6.58%
5Y
11.87%
10Y
—
Profit CAGR
1Y
23.45%
3Y
2.86%
5Y
20.12%
10Y
—
ROE
TTM
14.80%
3Y
15.98%
5Y
17.91%
10Y
—
ROCE
TTM
10.88%
3Y
15.26%
5Y
17.80%
10Y
—
Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
Krishna Institute of Medical Sciences Ltd (KIMS) is currently trading at 581.05 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Krishna Institute of Medical Sciences Limited (KIMS) is a major healthcare provider in India, operating a network of 12 multi-specialty hospitals predominantly in Telangana, Andhra Pradesh, and Maharashtra. In Q2 FY '26, KIMS reported total revenue of INR 965 crores, showcasing a significant year-on-year growth of 23.3%, despite traditionally being a quieter quarter for the sector. KIMS Hospital's innovative advancements include the introduction of a Medtronic major robotic guidance system in Telangana and a state-of-the-art XR experience lab in Gachibowli for augmented and virtual reality applications. Despite overall revenue growth, KIMS saw a decline in EBITDA and PAT, attributed mainly to the commissioning of new hospitals that have yet to reach profitability. The company continues to expand its footprint with recent openings in cities like Thane, and innovations in healthcare technology, which are likely to improve patient outcomes and operational efficiency.
Over the past 52 weeks, Krishna Institute of Medical Sciences Ltd has traded between a low of ₹474.55 and a high of ₹798.00. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Krishna Institute of Medical Sciences Ltd has a market capitalization of approximately 23,956.32. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Krishna Institute of Medical Sciences Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 72.92 and operates in the Healthcare sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
You can buy shares of Krishna Institute of Medical Sciences Ltd (KIMS) through any SEBI-registered stockbroker in India. A demat and trading account are required to place buy or sell orders on stock exchanges such as NSE or BSE. Shares are credited to the demat account as per the exchange settlement cycle.
Based on its market capitalization of 23,956.32 Cr, Krishna Institute of Medical Sciences Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Krishna Institute of Medical Sciences Ltd operates in the Healthcare sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Krishna Institute of Medical Sciences Ltd is 72.92. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
Krishna Institute of Medical Sciences Ltd currently does not pay dividends. Companies that do not pay dividends often reinvest profits to support business growth or strengthen operations.
Key risks associated with Krishna Institute of Medical Sciences Ltd include sector-specific challenges in the Healthcare industry, regulatory changes, competitive pressures, company-level financial performance, overall market volatility, and broader macroeconomic factors that can impact stock prices.
Bearish
4
Neutral
4
Bullish
6
Bearish
36
Neutral
4
Bullish
6
Bearish
32
Neutral
0
Bullish
0

Market Cap
₹ 23,956 Cr
P/E
72.92
Performance
STEADY PERFORMER
Valuation
OVERVALUED
Growth
SLUGGISH
Profitability
MODERATE MARGIN
Technicals
Bearish
Risk
MODERATE RISK
Turned 1 L into 3.07 L in last 5 Years